Previous close | 18.79 |
Open | 19.18 |
Bid | 19.82 x 1800 |
Ask | 19.86 x 800 |
Day's range | 18.89 - 19.93 |
52-week range | 17.24 - 26.56 |
Volume | |
Avg. volume | 243,183 |
Market cap | 910.683M |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.21 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 23.50 |
Comprehensive Analysis of Avanos Medical's Financial Performance and Strategic Progress
Avanos Medical (AVNS) delivered earnings and revenue surprises of -9.52% and 1.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results.